ClinicalTrials.Veeva

Menu

Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions

The Washington University logo

The Washington University

Status and phase

Completed
Phase 2

Conditions

Premalignant Vulvar Lesion
Benign Vulvar Lesion

Treatments

Drug: Cefazolin

Study type

Interventional

Funder types

Other

Identifiers

NCT03578965
201804136

Details and patient eligibility

About

A randomized control trial will provide the most reliable data to determine the role of prophylactic antibiotics to decrease the wound complication rate. The investigators plan to perform a pilot study to evaluate actual rates of wound complications and how long it takes to recruit 50 patients.

Enrollment

50 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All women, >=18 undergoing vulvar surgery
  • Biopsy proven benign or premalignant lesion requiring surgical management.
  • Women of childbearing age will be required to have a negative human chorionic gonadotropin (HCG) test within seven days of surgery.
  • Scheduled to undergo surgical management for their vulvar disease supervised by a faculty member within the Division of OBGYN at Washington University School of Medicine
  • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).

Exclusion criteria

  • Women who are pregnant
  • Women scheduled to undergo a radical vulvectomy
  • Women scheduled to undergo a concomitant graft, flap or plastic surgery
  • Women <18 years of age
  • History of prior vulvar radiation
  • Inability to sign an informed consent form prior to registration on study
  • Inability to understand spoken or written English
  • Prisoner

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

50 participants in 2 patient groups

Arm A: No antibiotic prophylaxis prior to skin incision
No Intervention group
Description:
-Women randomized to no antibiotic prophylaxis will not receive any antibiotics prior to skin incision.
Arm B: Antibiotic prophylaxis prior to skin incision
Experimental group
Description:
-Women randomized to prophylactic antibiotics will receive a cefazolin as per ACOG guidelines.
Treatment:
Drug: Cefazolin

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems